In this study, we demonstrated that FFAR2 was negatively involved in lung cancer progression induced by TLR2 and TLR3 through the suppression of the cAMP-AMPK-TAK1 signaling axis for the activation of NF-κB. The gene discussed is FFAR2; the disease is lung carcinoma.